NDC 50242-215
Xolair PFS
Omalizumab
Xolair PFS is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Genentech, Inc.. The primary component is Omalizumab.
| Product ID | 50242-215_2c703552-8c5b-4c50-b673-507f12080a27 |
| NDC | 50242-215 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Xolair PFS |
| Generic Name | Omalizumab |
| Dosage Form | Injection, Solution |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2018-09-28 |
| Marketing Category | BLA / BLA |
| Application Number | BLA103976 |
| Labeler Name | Genentech, Inc. |
| Substance Name | OMALIZUMAB |
| Active Ingredient Strength | 150 mg/mL |
| Pharm Classes | Anti-IgE [EPC],Decreased IgE Activity [PE],IgE-directed Antibody Interactions [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |